STABILISED DOSAGE FORMS OF AMLODIPINE BESYLATE

摘要

The present invention relates to a stable solid dosage form comprising 2-20 % by weight of amlodipine besylate, 10-70 % by weight polyols, at least a known pharmaceutical excipient, and having levels of impurity D (3-ethyl-5-methyl-2[(2-aminoethoxy)-methyl]-4-(2- chlorophenyl)-6-methylpyridine-3,5 dicarboxylate) less than 0,5 %.